会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Agents for treating neuropathic pain
    • 用于治疗神经性疼痛的药剂
    • US06642257B2
    • 2003-11-04
    • US09969644
    • 2001-10-04
    • Ichiro YamamotoManabu ItohFumiaki YamasakiYasushige AkadaYutaka MiyazakiShinichi Ogawa
    • Ichiro YamamotoManabu ItohFumiaki YamasakiYasushige AkadaYutaka MiyazakiShinichi Ogawa
    • A61K3144
    • C07D405/06C07D211/48C07D407/06C07D409/06
    • The present invention relates to a compound represented by Formula (I) below: (wherein A represents, for example, phenyl group substituted by R1 and R2, or an unsubstituted furyl group or an unsubstitued thienyl group; R1 represents, for example, hydrogen atom, fluorine atom, chlorine atom, trifluoromethyl group, nitro group, cyano group or methyl group while R2 represents, for example, hydrogen atom; R3 represents, for example, hydrogen atom or methyl group; R4 represents, for example, hydrogen atom or methyl group; R5 represents ethoxy group or isopropoxy group; X represents group: —CH(OH)— or methylene group; and Z represents, for example, a single bond or methylene group unsubstituted or substituted by hydroxyl group), and its salts, and medicinal compositions containing, as their active ingredient, the above compound or its salts. The compound of this invention, which is orally applicable, is highly effective for treating neuroapthic pain while presenting with fewer side-effects than do the conventional analgesics.
    • 本发明涉及由下式(I)表示的化合物:其中A表示例如被R 1和R 2取代的苯基或未取代的呋喃基或未取代的噻吩基; 1表示例如氢原子,氟原子,氯原子,三氟甲基,硝基,氰基或甲基,而R 2表示例如氢原子; R 3表示例如氢 原子或甲基; R 4表示例如氢原子或甲基; R 5表示乙氧基或异丙氧基; X表示基团:-CH(OH) - 或亚甲基; Z表示对于 例如,未取代或被羟基取代的单键或亚甲基)及其盐,以及含有作为其活性成分的上述化合物或其盐的药物组合物。 口服适用的本发明化合物对于治疗神经痛与非常有效,同时具有比常规止痛剂更少的副作用。
    • 7. 发明申请
    • Image processing apparatus and image processing method
    • 图像处理装置和图像处理方法
    • US20070171438A1
    • 2007-07-26
    • US11655845
    • 2007-01-22
    • Manabu Itoh
    • Manabu Itoh
    • H04N1/00
    • H04N1/0057H04N1/00591H04N1/00631H04N1/32635H04N1/32646
    • In one embodiment of an image processing apparatus, when multi-feeding during transport of originals is detected, except for the multi-fed originals, which are all of the originals simultaneously multi-fed by the multi-feeding, the images written on only the other remaining originals are recorded on recording paper; and a shifted discharge position in the discharge tray of only pre-multi-feeding original recording paper is different from a standard discharge position of other recorded recording paper, the pre-multi-feeding original recording paper being recording paper on which is recorded the image written on the original transported immediately before the original initially transported among the multi-fed originals.
    • 在图像处理装置的一个实施例中,当检测到传送原稿期间的多次进给时,除了由多次进给同时多次馈送的所有原稿的多次馈送原稿之外,仅在 其他剩余的原件记录在记录纸上; 并且只有预多份进纸的原始记录纸的排出托盘中的移动的排出位置与其他记录的记录纸的标准排出位置不同,所以预先进纸的原始记录纸是作为记录在其上的图像的记录纸 写在原始的原始运输之前,原始最初在多份原稿之间运输。
    • 8. 发明授权
    • 4-hydroxypiperidine derivatives having antiarrhythmic activity
    • 具有抗心律不齐活性的4-羟基哌啶衍生物
    • US06710060B2
    • 2004-03-23
    • US09969639
    • 2001-10-04
    • Ichiro YamamotoManabu ItohFumiaki YamasakiYutaka MiyazakiShinichi Ogawa
    • Ichiro YamamotoManabu ItohFumiaki YamasakiYutaka MiyazakiShinichi Ogawa
    • A61K31445
    • C07D405/06C07D211/48C07D407/06C07D409/06
    • The present invention relates to a compound represented by the following formula (I) or a salt thereof, or a pharmaceutical composition containing the compound as an effective ingredient: (wherein A represents, for example, phenyl group substituted with R1 and R2 or unsubstituted thienyl group; R1 and R2 each independently represent, for example, hydrogen atom, halogen atom or lower alkoxycarbonyl group; R3 represents, for example, hydrogen atom; R4 represents, for example, lower alkyl group; R5 represents, for example, lower alkoxy group; R6 represents, for example, hydrogen atom; R7 and R8 each represent, for example, hydrogen atom, respectively; X represents, for example, a single bond; Y represents, for example, methylene group or benzylidene group substituted with R1; and Z represents, for example, methylene group.) The compounds according to the present invention that do not suppress the transient sodium current of the cardiac muscle and do not manifest proarrhythimic activity is useful as a therapeutic agent for preventing and/or treating arrhythimia and for preventing sudden death.
    • 本发明涉及由下式(I)表示的化合物或其盐或含有该化合物作为有效成分的药物组合物:(其中A表示例如被R 1和R 2取代的苯基) 2或未取代的噻吩基; R 1和R 2各自独立地表示例如氢原子,卤素原子或低级烷氧基羰基; R 3表示例如氢原子; R 4, 表示例如低级烷基; R 5表示例如低级烷氧基; R 6表示例如氢原子; R 7和R 8各自表示例如氢 原子; X表示例如单键; Y表示例如被R 1取代的亚甲基或亚苄基; Z表示例如亚甲基。)根据本发明的化合物 不抑制心肌的瞬时钠电流,并不表现出血浆 节奏活动可用作预防和/或治疗心律失常并用于预防猝死的治疗剂。